Safety of regional citrate hemodialysis in acute renal failure.
Regional citrate anticoagulation is an alternative to heparin anticoagulation for hemodialysis of patients at increased risk of bleeding. We report the successful use of this technique in 326 dialyses in 49 high bleeding risk patients with acute renal failure. Systemic anticoagulation did not occur as a result of any dialysis procedure, and in no instance was bleeding observed. Dialysis was effective, as judged by removal of creatinine. The safety of this procedure is demonstrated by the lack of bleeding complications and the small incidence of electrolyte and acid-base abnormalities. In addition we document the absence of citrate intoxication by serial measurements of serum citrate levels. Regional citrate anticoagulation is a safe and effective method of performing hemodialysis in patients with acute renal failure at increased risk of bleeding.
Lohr
J W
JW
Department of Medicine, University of Kansas Medical Center, Kansas City.
Slusher
S
S
Diederich
D
D
D000136:Acid-Base Equilibrium / Q000187:drug effects; D058186:Acute Kidney Injury / Q000628:therapy*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000097:blood; D002951:Citrates / Q000008:administration & dosage* / Q000097:blood; D019343:Citric Acid; D003404:Creatinine / Q000493:pharmacokinetics; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006955:Hypernatremia / Q000209:etiology; D008297:Male; D006435:Renal Dialysis / Q000379:methods*; D012449:Safety
D000925:Anticoagulants; D002951:Citrates; D006454:Hemoglobins; D019343:Citric Acid; D003404:Creatinine